Article Text

Download PDFPDF
Unexpected outcome (positive or negative) including adverse drug reactions
Sensory neuropathy in paraneoplastic leucocytosis
  1. Florian Amor1,
  2. Massimo Bernardo2,
  3. Bruno Fattor1,
  4. Christian Josef Wiedermann1
  1. 1Department of Internal Medicine, Central Hospital of Bolzano, Bolzano, Italy
  2. 2Division of Palliative Care, Central Hospital of Bolzano, Bolzano, Italy
  1. Correspondence to Professor Christian Josef Wiedermann; christian.wiedermann{at}asbz.it

Granulocyte colony-stimulating factor (G-CSF) and granulocyte-macrophage colony-stimulating factor (GM-CSF) sensitise nerves to mechanical stimuli experimentally and may induce bone and muscle pain when used as supportive drugs. G-CSF and GM-CSF produced endogenously by tumour cells can cause paraneoplastic leucocytosis. Whether paraneoplastic leucocytosis is associated with changes in pain sensitivity is not yet clear. We report on a patient with advanced-stage thyroid cancer who developed extreme leucocytosis within a period of 4 weeks (103 000 white blood cells/mm3), composed mostly of neutrophils and eosinophils. Parallel to this leukemoid reaction, allodynia and hyperalgesia developed in the absence of tissue inflammation. The course of disease of an elderly male with advanced stage metastatic thyroid cancer with new onset neuropathic pain followed by the development of extreme leucocytosis in a leukemoid reaction suggests paraneoplastic release of myeloid CSFs. The coincidence of pain sensitisation and extreme leucocytosis suggests a causal contribution of G-CSF and GM-CSF.

Statistics from Altmetric.com

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Footnotes

  • Competing interests None.

  • Patient consent Obtained.